Browse EX-10 agreements

LEAR CORPORATION
2019 LONG-TERM STOCK INCENTIVE PLAN

(As Amended and Restated as of May 14, 2026)

Article 1.    Establishment, Objectives and Duration

1.1    Establishment of the Plan.Lear Corporation, a Delaware corporation (the “Company”), hereby establishes thisLear Corporation 2019 Long-Term Stock Incentive Plan, as set forth in this document and as may be amended or amended and restated from time to time (the “Plan”). Capitalized terms used but not otherwise defined herein will have the meanings given to them in Article 2. The Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Units, Restricted Stock Units, Performance Shares, Performance Units and other cash and equity incentive Awards. The Plan was first approved by the Committee on March 26, 2019, and by the Company’s shareholders on May 16, 2019 (the “Effective Date”). It was subsequently amended and restated on May 14, 2023, and the Company’s shareholders approved an increase in the number of Shares that could be awarded under the Plan.

…

Execution Version

AMENDMENT NO. 10, dated as of May 28, 2026 (this “Amendment”), to First Lien Credit Agreement, dated as of March 5, 2019 (as amended by the Technical Amendment, dated as of May 13, 2019, as supplemented by the Joinder Agreement, dated as of September 30, 2019, as amended by Amendment No. 1, dated as of January 30, 2020, as amended by Joinder Agreement and Amendment No. 2, dated as of June 30, 2020, as amended by Joinder Agreement and Amendment No. 3, dated as of October 7, 2020,as amended by Amendment No. 4, dated as of April 8, 2021, as amended by Joinder Agreement and Amendment No. 5, dated as of April 16, 2021, as amended by Joinder Agreement and Amendment No. 6, dated as of June 30, 2023, as amended by Joinder Agreement and Amendment No. 7, dated as of February 21, 2024, as amended by Joinder Agreement and Amendment No. 8, dated as of September 17, 2024, as amended by Amendment No. 9, dated as of December 11, 2024, and as otherwise amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”; and the C

…

May 20, 2026

Amit Muni

c/o Cohen & Steers, Inc.

1166 Avenue of the Americas

New York, New York 10036

Dear Amit,

We are pleased to offer you employment as an Executive Vice President, Chief Financial Officer at Cohen & Steers, Inc. (“Cohen & Steers”, or the “Company”) reporting to Joseph Harvey, Chief Executive Officer to commence no later than June 8, 2026 (the “Start Date”).

Base Salary and Term. You will be paid a salary at an annual rate of $450,000, less applicable deductions and in accordance with Cohen & Steers’ regular payroll practices, to compensate you for all hours you work, regardless of whether more or less than 40 in a regularly scheduled workweek. Salaries are reviewed annually, and adjustments (if any) will be based on your performance, prevailing economic conditions, and the firm’s profitability.

You will be paid on a semi-monthly basis on the 15th and the last business day of the month unless this regular payday occurs on a Saturday, Sunday, or holiday, in which case you will be paid on the last working day prior to the regular payday.

…

Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

Exhibit 10.2

Execution Version

AMENDMENT NO. 9

TO

DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

…

Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

Exhibit 10.3

Execution Version

AMENDMENT NO. 10 TO

DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

…

Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

Exhibit 10.1

                                        Execution Version

AMENDMENT NO. 8 TO

DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

…

MYRIAD GENETICS, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

(Effective: June 2026)

The following is a description of the standard compensation arrangements under which the non-employee directors of Myriad Genetics, Inc. (the “Company,” “our” or “we”) are compensated for their service as directors of the Company, including as members of the various committees of our Board of Directors (the “Board”).

Annual Retainer(all members)					$60,000
Chair of the Board					$120,000 additional retainer

…

EXECUTIVE CHAIRMAN OPTION SETTLEMENT AGREEMENT

THIS EXECUTIVE CHAIRMAN OPTION SETTLEMENT AGREEMENT (this “Agreement”) is entered into as of May 5, 2026, by and between Ryan Specialty Holdings, Inc., a Delaware corporation (the “Company”), and Patrick G. Ryan and Shirley W. Ryan, as trustees (collectively, the “Trustee”) of the Ryan Stock Option Trust, dated April 28, 2026 (the “Seller”) controlled by Patrick G. Ryan (the “Trustee”). Each of the Company and the Seller shall be a “Party” and together, the “Parties” for purposes of this Agreement.

RECITALS

WHEREAS, as of the date hereof, the Seller holds 1,800,000 shares of Class A common stock, par value $0.001 per share, of the Company (the “Class A Stock”);

WHEREAS, the Company has adopted the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan (as may be amended, restated or otherwise modified from time to time, the “Plan”), pursuant to which the Company may grant Stock Options and other equity-based awards to Eligible Individuals (as such terms are defined in the Plan);

…

								EXHIBIT 10.16

NON-QUALIFIED STOCK OPTION AWARD AGREEMENT
(EXECUTIVE CHAIRMAN OPTION)
PURSUANT TO THE
RYAN SPECIALTY HOLDINGS, INC. 2021 OMNIBUS INCENTIVE PLAN

* * * * *

Participant: [●]

Grant Date: [●]

Per Share Exercise Price: [●]

Number of Shares subject to this Option: [●]

* * * * *

THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (together with any appendix hereto, this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Ryan Specialty Holdings, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

…

| | |

| | |

AGREEMENT FOR TERMINATION OF LEASE
AND VOLUNTARY SURRENDER OF PREMISES

This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Lease Termination Agreement”) is made and entered into as of May 7, 2026 (the “Effective Date”) by and between ARE-MA Region No. 75, LLC, a Delaware limited liability company (“ARE”), and Werewolf Therapeutics, Inc., a Delaware corporation (“Tenant”) (each a “Party” and together, the “Parties”).

WHEREAS, on or about June 1, 2021, the Parties entered into a commercial lease agreement (the “Lease”) governing Tenant’s tenancy of a portion of the real property located at 200 Talcott Avenue, Watertown, Massachusetts 02472 (the “Premises”);

WHEREAS, the Lease expires on May 31, 2030 (“Lease Expiration Date”);

WHEREAS, Landlord and Tenant have agreed to terminate the Lease prior to the Lease Expiration Date pursuant to the terms, and subject to the conditions, set forth below.

…